» Articles » PMID: 8690909

Variation in HLA-DM Expression Influences Conversion of MHC Class II Alpha Beta:class II-associated Invariant Chain Peptide Complexes to Mature Peptide-bound Class II Alpha Beta Dimers in a Normal B Cell Line

Overview
Journal J Immunol
Date 1996 Mar 15
PMID 8690909
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The maturation of invariant chain (Ii):MHC class II complexes into peptide-loaded alpha beta dimers occurs by proteolytic removal of Ii chain and binding of antigenic peptides derived from exogenous and endogenous Ags. A fragment of the Ii chain (class II-associated invariant chain peptide (CLIP) remains associated with class II alpha beta and is an intermediate in this process. Conversion of alpha beta:CLIP complexes into alpha beta:peptide complexes is facilitated by HLA-DM. Two unique mAbs, specific for I-Ab bound to human CLIP and I-Ab bound to DR alpha peptide, were used to assess the formation of these peptide:class II complexes in a human B lymphoblastoid cell line (B-LCL) (Swei) transfected with I-A(b). In multiple independent Swei:I-Ab transfectants, the amount of human CLIP (hCLIP):I-Ab expressed was inversely proportional to the amount of DR alpha 52-68:I-Ab; quantitative differences in HLA-DM expression accounted for this phenotype. In the low DM transfectant, a substantial proportion of I-Ab, but not DR molecules, was altered structurally and unable to present native protein Ags. Addition of DM transgenes to the DM-low cells resulted in an increase in DR alpha 52-68:I-Ab coupled with a decrease in hCLIP:I-Ab complexes and restoration of exogenous protein Ag presentation. The DR5 molecules in Swei cells, which have a lower affinity for hCLIP than I-Ab, were not affected by low DM expression, suggesting that the amount of DM required for conversion of CLIP:class II to peptide:class II may depend on the affinity of the class II molecules for CLIP or DM.

Citing Articles

The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.

Sarango G, Richetta C, Pereira M, Kumari A, Ghosh M, Bertrand L EMBO Rep. 2022; 23(12):e55470.

PMID: 36215666 PMC: 9724678. DOI: 10.15252/embr.202255470.


Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4 T cell activation.

Alvaro-Benito M, Morrison E, Ebner F, Abualrous E, Urbicht M, Wieczorek M Cell Mol Immunol. 2018; 17(2):133-142.

PMID: 30467419 PMC: 7000412. DOI: 10.1038/s41423-018-0181-1.


Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.

Alvaro-Benito M, Morrison E, Abualrous E, Kuropka B, Freund C Front Immunol. 2018; 9:872.

PMID: 29774024 PMC: 5943503. DOI: 10.3389/fimmu.2018.00872.


Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells.

Crotzer V, Matute J, Arias A, Zhao H, Quilliam L, Dinauer M J Immunol. 2012; 189(8):3800-4.

PMID: 22984083 PMC: 3466399. DOI: 10.4049/jimmunol.1103080.


I-Ag7 is subject to post-translational chaperoning by CLIP.

Rinderknecht C, Lu N, Crespo O, Truong P, Hou T, Wang N Int Immunol. 2010; 22(8):705-16.

PMID: 20547545 PMC: 2908477. DOI: 10.1093/intimm/dxq056.